Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Intelligence

Set Alert for Market Intelligence

Canadian Body Welcomes Pharmacare Report

An interim report on implementing national pharmacare in Canada that highlights the importance of cost savings and access to medicines has been welcomed by local off-patent industry body the CGPA.

Market Intelligence Canada

Australia’s GBMA Aims To Educate With ‘Biosimilar Week’

Australia’s GBMA industry association will seek to promote biosimilars through a dedicated ‘Biosimilar Week’ in late April and early May this year, running as part of a three-year education program being pursued by the association and industry stakeholders.

Biosimilars Australia

Supply Issues Drive Up Metoprolol Prices In UK

Supply issues highlighted by UK pharmacists drove up local prices for generic metoprolol in February, according to the latest figures from market researcher WaveData.

United Kingdom Pricing Strategies

European Studies Help Plan A Path Forward For Value Added Medicines

Six value added medicines case studies across six European countries are featured in the latest IQVIA report for Medicines for Europe. Each of them, according to the association’s sector chair Arun Narayan, helps point to a way forward for value added medicines in Europe.

Europe Value-Added Medicines

Candesartan Climbs As Temazepam Tumbles In UK

As candesartan tablets saw their average UK trade prices leap by as much as five times in January, temazepam tablets plummeted by almost two-thirds, according to the latest figures from market researcher WaveData.

United Kingdom Pricing Strategies

France’s Gemme Warns Of Fragility Despite Sales Inching Upwards

French authorities must pull back from their reliance on price cuts as a source of savings and introduce a raft of measures to boost the use of generics against a backdrop of subdued growth, according to local off-patent industry association Gemme.

France Market Intelligence
See All
UsernamePublicRestriction

Register